Recombinant Human Pkm Protein，His

Pkm, or pyruvate kinase M, is a crucial enzyme involved in the glycolytic pathway, facilitating the conversion of phosphoenolpyruvate to pyruvate while generating ATP. The study of Pkm has gained significant interest due to its role in cellular metabolism, particularly in cancer biology. Cancer cells often exhibit altered metabolic pathways, favoring aerobic glycolysis, known as the Warburg effect, which allows for rapid growth and proliferation. Pkm exists in two main isoforms, M1 and M2, with M2 being predominantly expressed in tumors. Research has shown that the M2 isoform can promote cancer cell proliferation by influencing metabolic flux and supporting anabolic processes. Moreover, the regulation of Pkm activity is intricately linked with cellular signaling pathways, including those regulated by oncogenes and tumor suppressors. Understanding the structural and functional properties of recombinant Pkm, including its allosteric regulation and interaction with metabolites, is essential for developing targeted therapeutic strategies. Recent advances in recombinant protein technology have enabled the production of active Pkm for biochemical studies, facilitating investigations into its role in cancer metabolism and potential as a therapeutic target. Utilizing recombinant Pkm in research not only enhances our understanding of glycolytic regulation in cancer cells but also opens avenues for novel drug development aimed at reversing the metabolic adaptations of tumors. Overall, the exploration of Pkm provides vital insights into metabolism and its implications in oncogenesis, marking it as a promising candidate for further investigation in cancer therapeutics.